Development, Genotype, Reagent and Research - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Development

Genotype

Reagent

Research

Roche signs definitive share purchase agreement with long-term partner TIB.

The Pharma Data

SEPTEMBER 8, 2021

TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic. The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments. About TIB Molbiol.

Genotype

Genotype Reagent Genetics Research

Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

The Pharma Data

MARCH 16, 2022

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, It’s critical to quickly and accurately identify variants to inform ongoing research – including the ongoing development of therapeutics and vaccines.

In-Vitro

In-Vitro Genotype Reagent Protein

Roche signs definitive share purchase agreement with long-term partner TIB.

Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

Stay Connected